| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 3.90 | 82.2% |
| Total Income | 3.90 | 82.2% |
| Expenditure | 12.46 | 4.5% |
| PBT | -8.62 | 8.5% |
| Net Profit | -8.62 | 8.5% |
| OPM | — | |
| NPM | — | |
| EPS | -0.09 | 25.0% |
Hyperfine, Inc. Reports Q1 2026 Revenue Up 83% YOY
13 May 2026 · 13 May, 1:43 am
Summary
Hyperfine, Inc. announced its first quarter 2026 financial results, reporting revenues of $3.90 million, an 83% increase compared to the first quarter of 2025. The company's gross profit increased to $1.98 million, representing a 51% gross margin. Management expects full year 2026 revenue to be approximately $20 to $22 million, representing 55% growth compared to full year 2025. The company also secured $15.0 million in debt financing, extending the expected cash runway into 2028.
Key Highlights
- 1
Hyperfine, Inc. reported first quarter 2026 revenues of $3.90 million, an increase of 83% compared to $2.14 million in the first quarter of 2025.
- 2
The company sold 10 commercial Swoop® systems in Q1 2026, compared to six in Q1 2025.
- 3
Gross profit for the first quarter of 2026 was $1.98 million, compared to $0.88 million in the first quarter of 2025, representing a 51% gross margin compared to 41% gross margin.
- 4
Research and development expenses decreased by 24% to $3.85 million in the first quarter of 2026, compared to $5.04 million in the first quarter of 2025.
- 5
The company bolstered its balance sheet through $15.0 million debt financing, extending the expected cash runway into 2028.
- 6
Net loss for the first quarter of 2026 was $8.62 million, or $0.09 per share, compared to a net loss of $9.42 million, or $0.12 per share, for the first quarter of 2025.
- 7
Management continues to expect revenue for the full year 2026 to be approximately $20 to $22 million, representing 55% growth at the midpoint as compared to full year 2025.
Management Comments
Maria Sainz
“Our execution in Q1 was strong. We delivered our second-highest revenue quarter to date with over 80% year-over-year revenue growth, driven by our accelerating commercial engine. We believe the international regulatory clearances we secured, the clinical data we released to the neurology and stroke communities, and the continued momentum in our office and hospital businesses all indicate portable brain MRI is becoming mainstream, and we are leading the charge.”
Informational and educational content only. Not investment advice.